mo:re launches lab platform to set a new standard in animal-free drug development
Life Science startup introduces a laboratory platform to automate the planning, culture, and analysis of complex 3D cell culture models
mo:re, a German Life Science startup, has raised €2.3 million in seed funding to accelerate the commercialization of its lab platform for complex cell culture workflows. High-Tech Gründerfonds (HTGF) led the round, with participation from Innovationsstarter Fonds Hamburg (IFH), Gilson Inc., NEDGEX, Nidobirds Ventures, and Private Investors R&R Medical and Martin Blüggel.
There is much agreement in the scientific community that organoids represent a significant step in the evolution to more representative disease modelling. The path to faster approval of more relevant drugs includes modern organoid models. This has been recognized by the FDA as well with their new guidelines clearing the path to replacing animal experiments with relevant organoid models. The field is missing the means for broad application of organoids in higher throughput that achieves reproducible results in a standardized environment.
mo:re has developed a groundbreaking lab platform, combining automation and software for planning, executing, and analysis of cell culture studies. The user-friendly platform aims to simplify cell culture, making organoids accessible as a standard lab technique and providing verifiable results. The lab automation device covers all relevant process steps, setting a new benchmark for scalability, reproducibility, and standardization of 3D cell culture models.
“With this funding, we want to establish our presence in the market and continue building our team. Now it is time to focus our resources on developing further scientific applications to unlock the potential our platform has to offer together with our customers as well as our internal R&D lab”, Lukas Gaats , CEO at mo:re.
“The Team of mo:re is poised to execute on its vision to provide easy access to a standardized way of performing 3D cell culture and obtain reproducible results for researchers worldwide”, Dr. Christian Kannemeier, Senior Investment Manager at HTGF.
“Our investment in mo:re reflects our confidence in their visionary product to tackle cell culture challenges. Their platform can redefine the landscape of non-animal methods in the Life Science Industry”, Stefanie Höhn , Senior Investment Manager at IFH.
“Verifiable data in drug discovery and development are crucial for accelerating creation of new and effective pharmaceuticals. mo:re’s innovative technological approach provides an important step toward standardizing organoid growth, significantly enhancing their quality. This will not only improve the speed and reliability of drug discovery but also deliver more consistent results for research, ultimately reducing the reliance on animal testing,” Dirk Freystadt, SVP Corporate Development at Gilson Inc.
Other news from the department business & finance
These products might interest you
Limsophy by AAC Infotray
Optimise your laboratory processes with Limsophy LIMS
Seamless integration and process optimisation in laboratory data management
Laboperator, Labfolder & Labregister by labforward
Laboratory of the future: applications for a laboratory operating system
Labforward is creating the operating system of the lab by connecting data, teams & devices
Most read news
More news from our other portals
Something is happening in the life science industry ...
This is what true pioneering spirit looks like: Plenty of innovative start-ups are bringing fresh ideas, lifeblood and entrepreneurial spirit to change tomorrow's world for the better. Immerse yourself in the world of these young companies and take the opportunity to get in touch with the founders.
See the theme worlds for related content
Topic world Digitalization in the laboratory
The topic world Digitalization in the lab presents innovations and trends from digital data systems (ELN, LIMS) to laboratory robots and networked devices (IoT) to AI and machine learning.
Topic world Digitalization in the laboratory
The topic world Digitalization in the lab presents innovations and trends from digital data systems (ELN, LIMS) to laboratory robots and networked devices (IoT) to AI and machine learning.